Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration
Authors:
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 36 (2) , 109363
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA148688, PJT-162228)
- Children's Hospital Boston (R01CA148688, PJT-162228)
- Dana-Farber Cancer Institute (R01CA148688, PJT-162228)
- Hyundai Hope On Wheels (R01CA148688, PJT-162228)
- Canadian Institutes of Health Research (R01CA148688, PJT-162228)
- Sick Kids Foundation (R01CA148688, PJT-162228)
This publication has 70 references indexed in Scilit:
- IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)Nucleic Acids Research, 2013
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNature Genetics, 2012
- The many faces and functions of β‐cateninThe EMBO Journal, 2012
- Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in NeuroblastomaMolecular Therapy, 2011
- A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface ReceptorJournal of Biological Chemistry, 2010
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature, 2008
- Activating mutations in ALK provide a therapeutic target in neuroblastomaNature, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008